A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
Progressive impairment in lung function caused by chronic polymicrobial airway infection remains the major cause of death in patients with cystic fibrosis (CF). Cross-sectional studies suggest an association between lung function decline and specific lung microbiome ecotypes. However, longitudinal s...
Main Authors: | Marisa I. Metzger, Simon Y. Graeber, Mirjam Stahl, Olaf Sommerburg, Marcus A. Mall, Alexander H. Dalpke, Sébastien Boutin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.763121/full |
Similar Items
-
Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
by: Dario L. Frey, et al.
Published: (2022-05-01) -
Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
by: Julian Berges, et al.
Published: (2023-05-01) -
TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
by: Eva Steinke, et al.
Published: (2023-01-01) -
Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
by: Linus Piehler, et al.
Published: (2023-04-01) -
Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
by: Lena Wucherpfennig, et al.
Published: (2023-04-01)